Drug Discovery 2022: driving the next life science revolution
Fida Biosystems ApS
Where: C30
Flow Induced Dispersion Analysis (FIDA) is a revolutionary, first principle technology for in solution, accurate and reproducible measurement of hydrodynamic radius of biomolecules in complex matrices leading to a wide range of orthogonal biophysics assays.
It has been developed for quantification and characterization of proteins (including biologics) and particles up to 1.000 nm diameter, including complex interactions, stoichiometry, oligomeric states etc.
The FIDA technology is characterized by:
• Being fast (minutes)
• Requiring very small sample amounts (nl-μl)
• Being exceptionally tolerant to the sample matrix.
Contrary to most other procedures, the FIDA methodology is based on binding in homogenous solution; complications related to non-specific surface adsorption and challenging assay development is therefore avoided.
The unique features of FIDA enable characterization and quantification in native (biorelevant) environments. In-built assay quality control ensures high data reliability and walk-away automation sets free resources for other tasks.
Tel: + 45 53 72 78 70
Address: Generatorvej 6 A+B, Søborg
Website: https://fidabio.com/
Email: info@fidabio.com

Staff Attending

Mrs Joanne Walter
Strategic Accounts
Fida Biosystems ApS
Denmark

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2423